Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene
Authors:
Open Access
- 1 January 2012
- journal article
- Published by Medknow in Journal of Pharmacy and Bioallied Sciences
- Vol. 4 (5) , 14-6
Abstract
The objective of this study was to increase the oral bioavailability of Raloxifene having an absolute bioavailability only 2% due to extensive first pass hepatic metabolism by incorporating it in Solid Lipid Nanoparticles (SLNs). The optimized RSLNs prepared by Ultrasonic Emulsification and Low Temperature Solidification method showed the mean particle size, zeta potential and percentage drug entrapment of 101.4±3.5 nm, 19.4±0.279 mv, 97.67±1.02% respectively. The in-vitro intestinal permeability study indicated significantly higher permeation of the RSLNs than the marketed preparation. The in-vivo studies showed that pharmacokinetic parameters for the RSLNs were 3.5 times higher than the marketed preparation indicating significant increase in the oral bioavailability of the Raloxifene.Keywords
This publication has 2 references indexed in Scilit:
- Solid lipid nanoparticles Production, characterization and applicationsAdvanced Drug Delivery Reviews, 2001
- Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998